Navigation Links
Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C.
Date:10/14/2008

Also debuts TMR'09 campaign

IRVINE, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a global leader of innovative therapies for ischemic cardiac disease and the market leader of surgical products for transmyocardial revascularization (TMR), sponsored an educational symposium yesterday in conjunction with the 20th Annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.

The symposium, titled "New Horizons in Cardiac Regenerative Medicine: Advancements in Revascularization & Stem Cell Therapy," was attended by over 120 cardiology healthcare practitioners. The Program Chair was Warren Sherman, MD, Director of Cardiac Cell Based Endovascular Therapies, Center for Interventional Vascular Therapy, New York-Presbyterian Hospital/Columbia University Medical Center. Presenters included: Emerson Perin, MD, PhD, Director, New Interventional Cardiovascular Technology, Texas Heart Institute; Marvin Slepian, MD, Director of Interventional Cardiology, University of Arizona, Sarver Heart Center; and Keith Allen, Cardiothoracic Surgeon, Mid America Heart and Thoracic surgeons, Kansas City, MO.

"The program was designed to provide an update to clinicians on the recent developments with advanced cardiovascular revascularization and regenerative therapies, with a focus on patients suffering from ischemic cardiac disease," Dr. Sherman stated. "TCT attendees are eager to learn about rapidly evolving therapies, as well as the latest information on optimizing outcomes with available tools and techniques, including TMR as a sole therapy and adjunctive to bypass surgery."

Dr. Allen emphasized to the cardiologists in attendance, "Surgeons are innovating with Cardiogenesis to provide TMR with minimally invasive approaches, including surgical robotic delivery." He also discussed the early clinical experience with the PHOENIX combination delivery system being collected from c
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
2. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
3. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
4. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
5. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
6. Cardiogenesis Reports First Quarter 2008 Results
7. Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... life. The last stage, when two daughter cells split ... of cell biology in the Victorian era. For just ... this final step, when the dividing cell creates a ... to this process by those early biologists, cytokinesis, translates ... highly active and organized series of events. Scientists have ...
(Date:10/31/2014)... (PRCHN) at Case Western Reserve University School of ... million in federal grants awarded to improve community ... Disease Control and Prevention (CDC) renewed the PRCHN,s ... funds will support the center,s ongoing efforts in ... interventions that prevent and reduce chronic disease in ...
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review ... fat loss program ever developed. It promises to provide users ... is no wonder after all that this has become the ... nutrition and workout fat loss program was created by Joel ... to the author of this fat loss system, the method ...
(Date:10/31/2014)... At the start of 2014, numerous ... carbon monoxide poisoning in their homes. Now, as 2015 ... family-owned, Missouri-based heating and cooling company is taking a ... start the home heating season with the assurance that ... Beginning Nov. 1, 2014, E and Q Heating and ...
(Date:10/31/2014)... 2014 Energy Textiles has recently added ... gear is now available online, and Energy Textile is ... Celliant infrared-active athletic gear over compression gear. , ... has been signed for Under Armour to provide team ... eight years. In light of this decision, Energy Textiles ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4
... care enhancement program for patients with multiple chronic ... patient/family communications and their knowledge of their patients, ... at the Johns Hopkins Bloomberg School of Public ... of Annals of Family Medicine , found ...
... NY JULY 20, 2010 TCT 2010 (Transcatheter ... technologies and practices in interventional cardiology that will directly ... (September 21-25 in Washington, DC), late breaking data from ... cardiology techniques, and the interactions and effectiveness of new ...
... during and after pregnancy were able to cut the incidence ... study published in the British Journal of Dermatology ... at the Norwegian University of Science and Technology (NTNU), compared ... to women who were given a placebo. Use of the ...
... Reinberg HealthDay Reporter , MONDAY, July 19 (HealthDay ... of developing persistent ringing in the ear -- a condition ... one U.S. ear specialist called the data used for the ... a connection between cell phone use and tinnitus. The ...
... , MONDAY, July 19 (HealthDay News) -- People in an Alabama ... in their bodies were much more likely to have high blood ... PCBs actually caused their hypertension. If a direct connection does ... exposed to PCBs, which were once used in many products but ...
... in HIV/AIDS (BC-CfE) published an important study today in ... reinforces the view that the benefits of highly active ... to significantly preventing the transmission and spread of HIV. ... HIV, HAART uses a combination of drugs to stop ...
Cached Medicine News:Health News:Guided Care improves physician satisfaction with patient/family communications 2Health News:TCT 2010 to have significant impact on interventional cardiology practices and patient care 2Health News:Probiotics use in mothers limits eczema in their babies 2Health News:Can Cell Phones Cause Another Kind of Ringing? 2Health News:Could PCBs Help Boost Blood Pressure? 2Health News:Could PCBs Help Boost Blood Pressure? 3Health News:HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study 2Health News:HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study 3
(Date:10/31/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ... on the development of oral drug delivery systems, ... call to discuss the clinical results from its ... proprietary oral insulin capsules, to treat type 1 ... a.m. Eastern time. Shareholders and other ...
(Date:10/31/2014)... , October 31, 2014 ... Inc. (NASDAQ: NSPH ), Isis Pharmaceuticals Inc. ... HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... 30, 2014, the NASDAQ Composite ended at 4,566.14, up ...
(Date:10/31/2014)... British Journal of Urology ... discuss "male orgasmic dysfunction" with their doctor prior to ... symptoms while preserving sexual function     ... a paper in the British Journal of Urology International ... discuss with their doctors the likely impact of treatment ...
Breaking Medicine Technology:Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2
... Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or ... September 30, 2009. All figures included herein were prepared ... Mexican pesos. Also, the following consolidated figures show the Company,s ... , 3Q09 Highlights (vs. 3Q08) , During ...
... 26 ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer ... announced that it will release financial results for the third ... Monday, November 2, 2009. The Company will host a ... 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss ...
Cached Medicine Technology:Genomma Lab Internacional Announces Third Quarter 2009 Results 2Genomma Lab Internacional Announces Third Quarter 2009 Results 3ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call 2
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a ... microplate format. It is designed for the ... thyroglobulin (TG) in serum or plasma. The ... 1: Calibrators, controls and patient samples are ...
Medicine Products: